Literature DB >> 10663771

Spinal cord magnetic resonance imaging in suspected multiple sclerosis.

G J Lycklama à Nijeholt1, B M Uitdehaag, E Bergers, J A Castelijns, C H Polman, F Barkhof.   

Abstract

We examined the value of spinal cord magnetic resonance imaging (MRI) in the diagnostic work-up of multiple sclerosis (MS). Forty patients suspected of having MS were examined within 24 months after the start of symptoms. Disability was assessed, and symptoms were categorized as either brain or spinal cord. Work-up further included cerebrospinal fluid analysis and standard proton-density, T2-, and T1-weighted gadolinium-enhanced brain and spinal cord MRI. Patients were categorized as either clinically definite MS (n = 13), laboratory-supported definite MS (n = 14), or clinically probable MS (n = 4); four patients had clinically probable MS, and in nine MS was suspected. Spinal cord abnormalities were found in 35 of 40 patients (87.5 %), consisting of focal lesions in 31, only diffuse abnormalities in two, and both in two. Asymptomatic spinal cord lesions occurred in six patients. All patients with diffuse spinal cord abnormality had clear spinal cord symptoms and a primary progressive disease course. In clinically definite MS, the inclusion of spinal imaging increased the sensitivity of MRI to 100 %. Seven patients without a definite diagnosis had clinically isolated syndromes involving the spinal cord. Brain MRI was inconclusive, while all had focal spinal cord lesions which explained symptoms and ruled out other causes. Two other patients had atypical brain abnormalities suggesting ischemic/vascular disease. No spinal cord abnormalities were found, and during follow-up MS was ruled out. Spinal cord abnormalities are common in suspected MS, and may occur asymptomatic. Although diagnostic classification is seldom changed, spinal cord imaging increases diagnostic sensitivity of MRI in patients with suspected MS. In addition, patients with primary progressive MS may possibly be earlier diagnosed. Finally, differentiation with atypical lesions may be improved.

Entities:  

Mesh:

Year:  2000        PMID: 10663771     DOI: 10.1007/s003300050058

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  7 in total

1.  Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome.

Authors:  D T Okuda; E M Mowry; B A C Cree; E C Crabtree; D S Goodin; E Waubant; D Pelletier
Journal:  Neurology       Date:  2011-01-26       Impact factor: 9.910

Review 2.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 3.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

4.  Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.

Authors:  Jiwon Oh; Shiv Saidha; Min Chen; Seth A Smith; Jerry Prince; Craig Jones; Marie Diener-West; Peter C M van Zijl; Daniel S Reich; Peter A Calabresi
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

5.  Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis.

Authors:  R Zivadinov; A C Banas; V Yella; N Abdelrahman; B Weinstock-Guttman; M G Dwyer
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

6.  Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study.

Authors:  W Rashid; G R Davies; D T Chard; C M Griffin; D R Altmann; R Gordon; A J Thompson; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

7.  Negative prognostic impact of MRI spinal lesions in the early stages of relapsing-remitting multiple sclerosis.

Authors:  E D'Amico; F Patti; C Leone; S Lo Fermo; M Zappia
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.